LIG1 and cancer: As human LIG1 deficiency syndromes have been described17–19, and LigI is a promising target in ovarian cancer20, the mechanisms of lagging-strand DNA synthesis and associated DNA methylation and histone deposition dynamics in LigI deficient cells are relevant to understanding disease pathogenesis and the potential utility of LigI inhibition for treating cancer.